UniProtKB/SwissProt variant VAR

Variant information

Variant position:

95

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LP/P [Disclaimer]

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Proline (P) to Arginine (R) at position 95 (P95R, p.Pro95Arg).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from medium size and hydrophobic (P) to large size and basic (R)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

-2

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In ovarian cancer; somatic mutation.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs137852691 [ dbSNP | Ensembl ]

Sequence information

Variant position:

95

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

345

The length of the canonical sequence.

Location on the sequence:

LYAGNDKWSIDPRVIILVNT P TQYSIMIQNVDVYDEGPYTC

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         LYAGNDKWSIDPRVIILVNTPTQYSIMIQNVDVYDEGPYTC

Chimpanzee                    LYAGNDKWSIDPRVIILVNTPTQYSIMIQNVDVYDEGPYTC

Rat                           LYAGNDKWSIDPRVIILVNTPTQYSIMIQNVDVYDEGPYTC

Bovine                        LYAGNDKWSIDPRVIILVNTPTQYSIMIQNVDVYDEGPYTC

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	28 – 322	Opioid-binding protein/cell adhesion molecule
Domain	39 – 126	Ig-like C2-type 1
Disulfide bond	57 – 115

Literature citations

OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer.
Sellar G.C.; Watt K.P.; Rabiasz G.J.; Stronach E.A.; Li L.; Miller E.P.; Massie C.E.; Miller J.; Contreras-Moreira B.; Scott D.; Brown I.; Williams A.R.; Bates P.A.; Smyth J.F.; Gabra H.;
Nat. Genet. 34:337-343(2003)
Cited for: VARIANT OVARIAN CANCER ARG-95;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q14982: Variant p.Pro95Arg